Perioperative outcomes of laparoendoscopic single-site extracorporeal versus intracorporeal cystectomy for benign ovarian cysts: a retrospective cohort study based on propensity score matching.

BACKGROUND: Ovarian cysts are the most common gynecological disease, and laparo-endoscopic single-site (LESS) cystectomy is a popular surgical procedure. A new laparoscopic technique combining the advantages of LESS surgery and open surgery has been introduced to treat large ovarian cysts. To our knowledge, no previous research has compared LESS-extracorporeal (LESS-E) cystectomy to LESS-intracorporeal (LESS-I) cystectomy. This study compared the perioperative results of LESS-E cystectomy and LESS-I cystectomy in the treatment of benign ovarian cysts.
METHODS: Two hundred eighty-eight cases of cystectomy from our institutional database were retrospectively reviewed. 1:1 propensity score matching (PSM) was performed to minimize bias due to any imbalanced baseline features between the 2 groups, which were matched in terms of age, body mass index, and the largest diameter of ovarian cysts. Seventy-nine cases were then selected from each group, and the perioperative outcomes of the 2 cohorts were analyzed.
RESULTS: The mean (standard deviation) largest diameter of ovarian cysts was 8.30 (3.56) cm in the LESS-I group and 9.14 (3.15) cm in the LESS-E group (P=0.118). No statistically significant difference was found between the 2 groups in terms of estimated blood loss, postoperative hemoglobin decline, postoperative pain in 24 hours, postoperative hospital stay, and total hospital costs (P>0.05). However, the mean operation time of the LESS-E group was shorter than that of the LESS-I group (85.01 vs. 104.25 minutes; P=0.001). Additionally, the spillage rate of the LESS-I group was significantly greater than that of the LESS-E group (46.8% vs. 17.7%; P<0.001). The mean pain scores at 6 postoperative hours as measured by a visual analogue scale were significantly greater in the LESS-I group than the LESS-E group (3.85 vs. 3.37; P=0.016).
CONCLUSIONS: LESS-E cystectomy is a safe and feasible approach with a shorter operation time and lower spillage rate than LESS-I cystectomy. 2021 Annals of Translational Medicine. All rights reserved.

Introduction

Ovarian cysts are the most common gynecological disease and frequently appear in females of reproductive age (1). According to different types of ovarian cysts, the treatment methods are also different, including observation, medicine treatment, aspiration and surgery. For patients with surgical indications, open surgery or laparoscopic surgery are optional. At present, minimally invasive surgery is the mainstream surgical method for the treatment of benign ovarian cysts, which has a number of undeniable benefits over laparotomy, including less postoperative pain, fewer postoperative complications, a faster recuperation time, and a shorter hospital stay (2-4).

In recent decades, surgeons have strived to reduce the size, number, and placement of incisions to minimize abdominal wall trauma, and with the development of optical devices, surgical instruments, and ports, laparoendoscopic single-site (LESS) surgery has become a popular surgical procedure (5,6). LESS surgery has outstanding cosmetic advantages, as the surgical scar is largely concealed within the umbilicus, a natural embryonic orifice (7). Extensive studies have proven the feasibility and security of the LESS surgical procedure in the treatment of benign ovarian cysts (8-16). Schmitt et al. (17) conducted a meta-analysis of 841 patients who underwent LESS and conventional laparoscopy for ovarian cystectomy demonstrated that postoperative pain, operative blood loss, cosmetic results and postoperative complication rates are comparable between both techniques. Kim et al. (18) reported that LESS had fewer ports than conventional group and the postoperative pain was less. Another study (19) showed that the LESS group had a significantly lower postoperative pain score and analgesics requirement compared to the conventional group.

However, large ovarian cyst surgery faces a number of challenges, including technical challenges, a limited operating space for the use of endoscope instruments, and unexpected spillage during Veress needle or trocar insertion (1). A new laparoscopic technique combining the advantages of LESS surgery with those of open surgery has been introduced. After the suction of the fluid contents, the cyst is pulled out through the umbilicus, and the extracorporeal cystectomy is then performed, followed by an inspection of the whole peritoneal cavity and careful irrigation (20-22). The feasibility and safety of such LESS surgery for the treatment of very large ovarian cysts has been proved (22-25). LESS-extracorporeal (LESS-E) cystectomy has several advantages, including the ease of switching between extracorporeal and intracorporeal approaches, the low relative risk of spillage, and excellent cosmetic results (22).

As far as we are aware, no previous research has compared LESS-E cystectomy with LESS-intracorporeal (LESS-I) cystectomy. While we found that patients in our hospital with equal diameter of ovarian cysts conducted both surgical procedures. The research question driving this study is: what kind of surgery is more beneficial to patients? A retrospective cohort study based on propensity score matching (PSM) was designed to compare the perioperative results of LESS-E and LESS-I cystectomy in the treatment of benign ovarian cysts. We present the following article in accordance with the STROBE reporting checklist (available at https://dx.doi.org/10.21037/atm-21-5625).

Methods

288 patients, who underwent LESS cystectomy between August 1, 2016 and October 29, 2019 at The First Affiliated Hospital of the Army Medical University, were retrospectively reviewed in this study. Of these 288 patients, 45 were excluded, as they met 1 of the following exclusion criteria: (I) the pathological results revealed malignant or borderline tumors; (II) a hysteromyomectomy was conducted; (III) the patient was pregnant; or (IV) a bilateral cystectomy was conducted. Of the final 243 patients, 105 patients underwent LESS-E cystectomy and 138 patients underwent LESS-I cystectomy. 1:1 PSM was performed to minimize any bias due to the imbalanced baseline features between the 2 groups, and the 2 groups were matched in terms of age, body mass index (BMI), and the largest diameter of ovarian cysts. Seventy-nine cases from each group were then selected (see ). All procedures performed in this study involving human participants were in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Ethics Committee of The First Affiliated Hospital, Army Medical University (approval No. KY202024). Individual consent for this retrospective analysis was waived.

Figure 1

Flowchart of group allocation. a, 1 of the 2 associated with bilateral cystectomy; b, associated with bilateral cystectomy; c, 2 of the 3 associated with bilateral cystectomy. LESS, laparo-endoscopic single-site; LESS-I, LESS-intracorporeal; LESS-E, LESS-extracorporeal; PSM, propensity score matching.

Surgical technique

Both techniques were conducted on a single-access multichannel port with 2 parts, a detachable port cap with 4 access ports (2 12-mm ports and 2 5-mm ports), and a 70-mm retractor component. The patients in both groups were placed under general endotracheal anesthesia and placed in a dorsal lithotomy position. A Foley catheter was inserted into the bladder, and a uterine manipulator via vaginal access was used for uterine manipulation. A vertical skin incision (ranging from 2 to 2.5 cm in size) was made, followed by a peritoneal and fascial incision at the midline of the umbilicus. A wound retractor (to which a port cap was affixed) was inserted into the incision. The intra-peritoneal pressure of pneumoperitoneum was maintained at 12 mmHg. A 10-mm, 30-degree laparoscope was then inserted through the 12-mm port to explore the peritoneal surface, omentum, contralateral ovary, and ovarian cyst. In cases of mild adhesion, the adhesiolysis was performed using conventional laparoscopic instruments through the single-port channel. Subsequently, the mobility of the adnexal mass and the extensibility of adnexal ligaments for delivery through the umbilical incision were evaluated.

The detachable port cap in the LESS-E group was then removed to start the extracorporeal process. After identifying the mass, a purse-string suture was used at the corners of the cystic surface, which was exposed with a wound retractor (see ). The cyst was then punctured through the suture, and a suction tip was used to rapidly aspirate its contents. A Kelly clamp was used to hold the puncture site on the cyst, and pieces of surgical gauze were used to cover the internal edge of the wound retractor to prevent the spillage of cystic content. Upon exteriorization, the ovarian cyst was encircled with wet wide surgical gauze to avoid tissue dryness and extracorporeal spillage throughout the surgery. Next, common surgical instruments were used to completely separate the cystic capsule from the normal tissue as in open surgery (see ). After completing the ovarian cyst enucleation (see ), the remaining tissues were remodeled with 3-0 absorbable sutures (see ). Upon the completion of the extracorporeal step, the ovary was immediately returned to the abdominal cavity (see ). Once the port cap was reset, the laparoscope and laparoscopic devices were inserted, and the abdominal cavity was copiously irrigated with normal saline after careful observation for any bleeding foci or pathological findings. The fascia and peritoneum of the umbilicus were closed, layer by layer, with 2-0 absorbable sutures, after which the skin incision was closed with 4-0 absorbable intracutaneous stitches (see ).

Figure 2

The procedure of LESS-E cystectomy. (A) Exteriorization of the tumor capsule; (B) separation of the cystic capsule and normal tissue; (C) ovarian cyst enucleation was completed; (D) remodeling of remnant ovarian tissues; (E) intra-pelvic appearance after cystectomy; (F) postoperative umbilical wound. LESS-E, laparoendoscopic single-site-extracorporeal.

The procedure used in the LESS-I group was similar to that performed in conventional laparoscopic surgery. After placing the ovary in a specimen bag, laparoscopic enucleation was then performed to prevent intra-peritoneal spillage. First, endoshears were used to incise the antimesenteric border of the ovary. Second, after identifying the cyst wall, a bidirectional dissection of the surrounding ovarian cortex was performed using a combination of electrocoagulation, traction, and counter-traction, and the sharp and blunt technique. Third, the bed was carefully examined and bleeding areas were safeguarded by cauterization after the ovarian cyst was excised. Fourth, the remaining tissues were remodeled with 3-0 absorbable sutures. Finally, after specimen removal, similar steps were performed to those described above for the LESS-E procedure.

Patient data, including the operative time, cyst content spillage rate, estimated blood loss, postoperative pain, postoperative exhaust time, postoperative out-of-bed time, postoperative hospital stay, final pathology, and demographic information were collected. Any cyst content found in the pelvic cavity after the completion of the cystectomy was defined as positive spillage. The duration of the surgery was timed, starting with the skin opening and ending with the skin closure. Total blood loss during the operation was estimated by deducting the saline used to wash out the abdominal cavity and the total amount of the cyst content from the total volume of fluid aspirated. Postoperative pain was evaluated using a visual analogue scale (VAS) at 6 and 24 hours after the operation.

Statistical analysis

1:1 PSM was performed using SPSS Statistics 26.0 software. The covariates used in matching included age, BMI, and the largest diameter of the cysts, and the matching tolerance was 0.1. The mean ± standard deviation (SD) was used to express continuous variables that conformed to a normal distribution, and t-tests were used for comparisons between the groups; otherwise, the Mann-Whitney test was used, and the results were described as the median [interquartile range (IQR)]. The Fisher exact test or the chi-square test was used to analyze categorical variables. A P value less than 0.05 (P<0.05) was considered statistically significant.

Results

In this study, 105 patients underwent LESS-E cystectomy and 138 patients underwent LESS-I cystectomy. Using PSM with a matching tolerance of 0.1, a total of 79 patients in each group were matched. The standardized differences before and after the matching of each covariate are shown in . Notably, the standardized differences of the covariates after matching were reduced, and the imbalance in distribution of the covariates was decreased.

Table 1

Comparison of the standardized differences of each covariate before and after PSM

Before and after matching	Age (years)	BMI (kg/m2)	Maximum diameter of cyst (cm)
Before matching
LESS-E	27.88±7.78	21.12±3.15	10.35±3.88
LESS-I	27.77±8.19	21.49±3.12	7.24±3.04
Comparison between groups	F=0.433, P=0.917	F=0.761, P=0.384	F=7.754, P<0.001
Standardized difference	0.0147	0.1180	0.8923
After matching
LESS-E	28.39±7.41	21.08±3.17	9.14±3.15
LESS-I	28.90±8.77	21.36±3.11	8.30±3.56
Comparison between groups	F=2.965, P=0.696	F=0.183, P=0.573	F=0.827, P=0.118
Standardized difference	0.0628	0.0892	0.2499

PSM, propensity score matching; LESS-I, LESS-intracorporeal; LESS-E, LESS-extracorporeal; BMI, body mass index.

The characteristics of the selected patients are set out in . The mean age of patients in the LESS-I group and LESS-E group was 28.90±8.77 and 28.39±7.41 years (P=0.696), respectively. The pathological findings between the groups were similar (P=0.880). A mature cystic teratoma was the most common pathological feature in both groups. The mean (SD) largest diameter of the ovarian cysts was 8.30 (3.56) cm in the LESS-I group and 9.14 (3.15) cm in the LESS-E group (P=0.118). There was no significant difference in the characteristics between the 2 groups (P>0.05).

Table 2

Patients’ characteristics

Characteristics	LESS-I (n=79)	LESS-E (n=79)	P value
Age (years)	28.90±8.77	28.39±7.41	0.696
Height (cm)	160.08±5.02	159.49±4.81	0.458
BMI (kg/m2)	21.36±3.11	21.08±3.17	0.573
Previous abdominal surgeries (%)	18 (22.8)	12 (15.2)	0.224
Previous cesarean sections (%)	15 (19.0)	10 (12.7)	0.276
Maximum diameter of cyst (cm)	8.30±3.56	9.14±3.15	0.118
CA125 (U/mL)	18.53 (13.78–31.99)	21.53 (13.63–37.95)	0.396
Pathologic findings			0.880
Mature cystic teratoma (%)	41 (51.9)	39 (49.4)
Endometrioma (%)	14 (17.7)	18 (22.8)
Mucinous/serous cystadenoma (%)	18 (22.8)	17 (21.5)
Other benign tumor (%)	6 (7.6)	5 (6.3)

Other benign tumors included simple cyst, paraovarian cyst, corpus luteum cyst, follicular cyst, and ovarian fibroma. Data are presented as mean ± SD, median (IQR) and n (%). LESS-I, LESS-intracorporeal; LESS-E, LESS-extracorporeal; BMI, body mass index; CA125, cancer antigen 125.

The perioperative results are set out in . Rupture of the cyst was observed in 14 of 79 (17.7%) patients in the LESS-E group, a figure significantly lower than that observed in the LESS-I group of 37 of 79 (46.8%) (P<0.001). The mean operation time, calculated from the beginning of skin incision to skin closure, was shorter in the LESS-E group than the LESS-I group [85.01 (27.67) vs. 104.25 (40.54) minutes; P=0.001]. The mean postoperative pain scores at 6 hours after surgery (measured using VAS scores) were significantly lower in the LESS-E group than the LESS-I group [3.37 (1.16) vs. 3.85 (1.31); P=0.016]. There was no statistically significant difference in terms of the estimated blood loss, pelvic adhesion, postoperative hemoglobin decline, postoperative exhaust time, postoperative out-of-bed time, postoperative pain in 24 hours, postoperative hospital stay, and total hospital costs (P>0.05).

Table 3

Comparison of the surgical results and perioperative complications in the 2 groups

Variable	LESS-I (n=79)	LESS-E (n=79)	P value
Operative time (min)	104.25±40.54	85.01±27.67	0.001
Estimated blood loss (mL)	50 [30–100]	50 [20–100]	0.856
Cyst rupture (%)	37 (46.8)	14 (17.7)	<0.001
Pelvic adhesion (%)	30 (38.0)	33 (41.8)	0.626
Transfusion	0	0
Total hospital cost (CNY)	15,546.82±2,044.29	14,965.86±2,791.62	0.138
Post operation day	3.54±1.13	3.41±1.42	0.496
Postoperative fever	3	1
ΔHb (g/dL)	1.56±0.71	1.74±0.84	0.150
Postoperative pain scores
At 6 h	3.85±1.31	3.37±1.16	0.016
At 24 h	1.54±0.57	1.43±0.52	0.194
Postoperative exhaust time (h)	18 [13–22]	18 [13–22]	0.950
Postoperative out-of-bed time (h)	15.84±2.49	15.46±1.79	0.273

Data are presented as mean ± SD, median (IQR) and n (%), ΔHb, postoperative hemoglobin decline. LESS-I, LESS-intracorporeal; LESS-E, LESS-extracorporeal.

No intraoperative complications that required treatment occurred in either group. In relation to postoperative complications, 3 patients in the LESS-I group had a fever, and 1 patient in the LESS-E group had a fever. No conversion to laparotomy was needed in the LESS-E group, and no additional trocars were needed in the LESS-I group. In a 3-month follow-up, there was no postoperative fever or incisional hernia in the two groups. And the scar is almost invisible.

Discussion

To our knowledge, the present study is the first cohort comparison of the LESS-E and LESS-I approaches in the treatment of benign ovarian cystectomy. Both groups successfully completed the operation without conversion to multiport laparoscopic or open surgery. Compared to LESS-I, LESS-E resulted in a lower rate of cystic content spillage (P<0.001), a reduced operation time (P=0.001), and decreased VAS scores at 6 hours after surgery (P=0.016). There was no statistically significant difference in terms of estimated blood loss, postoperative pain in 24 hours, postoperative hemoglobin decline, postoperative hospital stay, and total hospital costs (P>0.05).

A previous multivariate regression analysis (26) indicated that only the cystectomy procedure and cyst size were significantly and positively associated with inadvertent cyst rupture in the laparoscopic removal of adnexal cysts. Notably, during cystectomy, there is a greater risk of malignancy in bigger cysts, which is accompanied by a risk of iatrogenic spillage of malignant cells. Thus, reducing cystic content spillage is of great significance in decreasing pelvic-abdominal metastasis and patient prognosis (27). In this context, the mean diameter of the cysts in the LESS-I group was comparable to that in the LESS-E group (8.3±3.56 vs. 9.14±3.15 cm; P=0.118). The spillage rate was dramatically lower in the LESS-E group than the LESS-I group (17.7% vs. 46.8%; P<0.001). This is mainly because the space constraint in the LESS-I group makes instrumentation difficult and cystectomy rupture possible (27). In the LESS-E group, using a Kelly clamp to hold the cyst wall, a purse-string suture to close the puncture hole, and pieces of surgical gauze to cover the inner edge of the wound retractor can reduce cystic fluid leakage during the intracorporeal procedure (21,24). Our results were similar to those of a previous study (28) that compared single-port-access pure laparoscopic surgery (SPA-PLS) with single-port-access hand-assisted laparoscopic surgery (SPA-HALS) for adnexal tumors for which there were 33 cases (31.3%) and 4 cases (10.3%) of intracorporeal spillage in the SPA-PLS group and the SPA-HALS group, respectively (P=0.005). Another case-control study (1) compared conventional laparoscopy with single-port assisted extracorporeal ovarian cystectomy in the treatment of benign ovarian cysts found a significantly lower spillage rate in the latter (69.7% vs. 8.0%; P<0.001). Kim (20) reported on 22 patients with ovarian cysts diameter >8 cm who underwent transumbilical single-port laparoscopic-assisted adnexal surgery. In that study, 20 of the 22 cases were completed successfully, and cyst rupture only occurred in 2 cases (10%).

We found that the operation time of the LESS-E group was significantly less than that of the LESS-I group (P=0.001). Conversely, Roh et al. (28) compared 43 cases of SPA-HALS with 96 cases of SPA-PLS for adnexal tumors and found that there was no statistically significant difference in the operation times between the 2 groups (P=0.947). The difference between these results and our results may be due to selection bias and the median tumor size being notably smaller in the SPA-PLS group than the SPA-HALS group (6.3 vs. 10.9 cm; P<0.001). Using the LESS-E approach, the cystic capsule was extracorporeally resected from the normal ovarian tissue, which enabled more precise dissection than the LESS-I approach. Further, the rapid remodeling of the ovarian tissue is possible in LESS-E approach, as in laparotomy, which significantly shortens the operation time.

Postoperative pain after laparoscopic surgery consists of incisional pain and deep abdominal (visceral) pain (29). The lower level of postoperative pain at 6 hours in patients who underwent LESS-E cystectomy might be due to the LESS-E cystectomy having a shorter incision expansion time than the LESS-I cystectomy. Furthermore, carbon dioxide pneumoperitoneum can cause postoperative shoulder pain due to phrenic nerve irritation (30). Once the detachable port cap was removed in the LESS-E cystectomy, the patient was turned to the supine position without pneumoperitoneum. Conversely, in the LESS-I group, pneumoperitoneum persisted throughout the operation. Thus, the LESS-E group had a lower VAS score at 6 hours after surgery. No statistically significant difference was found in VAS scores at 24 hours after surgery between the 2 groups due to the absorption of residual carbon dioxide.

For the women in our study, who had a mean age of 28.90 years in the LESS-I group and 28.39 years in the LESS-E group, apart from an invisible scar, the preservation of fertility was also important. Mohamed et al. (31) reported that laparoscopic ovarian cystectomy, as compared to laparotomy, is associated with a significant reduction in the ovarian reserve. While the method of cyst enucleation and ovarian suture we use in LESS-E approach is the same as laparotomy, which can preserve normal ovarian tissues to the greatest extent. Further, as no coagulation of ovarian tissue was needed under direct vision, the damage to ovarian parenchyma and ovarian stromal blood vessels was decreased. Unfortunately, no anti-Mullerian hormone (AMH) test was conducted in our study that reflects ovarian function.

A previous study (32) described possible ovarian ligament damage during the process of the extracorporeal extraction of ovarian cysts through an umbilical incision. However, in another study, the author suggested that these tumors may be completely exteriorized through an umbilical incision because the pelvic peritoneum, adnexal ligaments, and salpinx become overstretched as tumors grow in size (28). We did not observe any injuries to the adnexal ligaments or tubes; however, such injuries are a risk of this approach, and we acknowledge that it is an important issue in the performance of this procedure. Thus, further research on LESS-E cystectomy with the mobilization of adnexal tumors needs to be conducted to analyze this risk.

The limitations of this study include its retrospective design, insufficient samples, and a lack of AMH results that made it impossible to evaluate changes in the ovarian reserve. Prospective studies need to be designed to further confirm the advantages of LESS-E cystectomy, which may benefit most women.

In conclusion, this is the first cohort study to compare LESS-E to LESS-I cystectomy in the treatment of benign ovarian cysts. LESS-E cystectomy is feasible and has comparable surgical results to those of LESS-I cystectomy. Further, no increase in perioperative complications was observed. More importantly, LESS-E cystectomy was found to be associated with a lower spillage rate and a reduced operation time in the selected women.

The article’s supplementary files as